Finally, A-to-I editing on the lncRNA prostate cancer antigen 3 (PCA3) enhanced its ability to bind and suppress the PRUNE2 pre-mRNA, thus promoting cancer cell proliferation, adhesion and migration [127]. Here, PCA3 is linked to cancer.